Xiao Jie Liu

Director/Board Member at YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.

42 year

Health Technology

Consumer Services

Commercial Services

Profile

Xiao Jie Liu is currently the Board Secretary, Director & Deputy General Manager at Yantai Dongcheng Biochemicals Co., Ltd.
since 2022.
He is also currently a Director at MITRO Biotech Co., Ltd.
since 2020.
Previously, he worked as an Accounting Manager at Yantai Dongcheng Biochemicals Co., Ltd.
Mr. Liu completed his undergraduate degree at Shandong University of Finance & Economics.

Xiao Jie Liu active positions

Companies	Position	Start
YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.	Director/Board Member	2022-05-18
Mitro Biotech Co., Ltd. Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China.	Director/Board Member	2020-07-24

All active positions of Xiao Jie Liu

Former positions of Xiao Jie Liu

Companies	Position	End
YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.	Public Communications Contact	-

See the detail of Xiao Jie Liu's experience

Training of Xiao Jie Liu

Shandong University of Finance & Economics

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Xiao Jie Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.	Health Technology

Private companies	1
Mitro Biotech Co., Ltd. Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China.	Commercial Services